Document And Entity Information
Document And Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Mar. 16, 2023 | Jun. 30, 2022 | |
Document Information [Line Items] | |||
Entity Central Index Key | 0001063537 | ||
Entity Registrant Name | RiceBran Technologies | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --12-31 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2022 | ||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2022 | ||
Document Transition Report | false | ||
Entity File Number | 001-36245 | ||
Entity Incorporation, State or Country Code | CA | ||
Entity Tax Identification Number | 87-0673375 | ||
Entity Address, Address Line One | 25420 Kuykendahl Rd., Suite B300 | ||
Entity Address, City or Town | Tomball | ||
Entity Address, State or Province | TX | ||
Entity Address, Postal Zip Code | 77375 | ||
City Area Code | 281 | ||
Local Phone Number | 675-2421 | ||
Title of 12(b) Security | Common Stock, no par value per share | ||
Trading Symbol | RIBT | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 34,300,000 | ||
Entity Common Stock, Shares Outstanding | 6,384,334 | ||
Auditor Firm ID | 49 | ||
Auditor Name | RSM US LLP | ||
Auditor Location | Houston, Texas |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 3,941 | $ 5,825 |
Accounts receivable, net of allowance for doubtful accounts of $27 and $18 | 3,703 | 4,136 |
Inventories | 2,378 | 2,444 |
Other current assets | 1,046 | 810 |
Total current assets | 11,068 | 13,215 |
Property and equipment, net | 14,207 | 15,444 |
Operating lease right-of-use assets | 1,778 | 2,127 |
Intangible assets | 380 | 527 |
Total assets | 27,433 | 31,313 |
Current liabilities: | ||
Accounts payable | 1,232 | 826 |
Commodities payable | 1,546 | 1,702 |
Accrued salary, wages and benefits | 696 | 787 |
Accrued expenses | 1,124 | 683 |
Operating lease liabilities, current portion | 391 | 382 |
Due under line of credit | 3,150 | 3,379 |
Due under insurance premium finance agreements | 185 | 128 |
Finance lease liabilities, current portion | 125 | 86 |
Long-term debt, current portion | 996 | 1,183 |
Total current liabilities | 11,364 | 9,156 |
Operating lease liabilities, less current portion | 1,557 | 1,948 |
Finance lease liabilities, less current portion | 325 | 100 |
Long-term debt, less current portion | 1,296 | 1,356 |
Derivative warrant liability | 69 | 258 |
Total liabilities | 14,524 | 12,818 |
Commitments and contingencies | ||
Shareholders' equity: | ||
Preferred stock, 20,000,000 shares authorized: Series G, convertible, 3,000 shares authorized, stated value $150, 150 shares, issued and outstanding | 75 | 75 |
Common stock, no par value, 15,000,000 shares authorized, 6,309,509 shares and 5,158,967 shares, issued and outstanding | 328,551 | 326,279 |
Accumulated deficit | (315,717) | (307,859) |
Total shareholders' equity | 12,909 | 18,495 |
Total liabilities and shareholders' equity | 27,433 | 31,313 |
Line of Credit With Bank [Member] | ||
Current liabilities: | ||
Due under line of credit | $ 1,832 | $ 0 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Accounts receivable, allowance for doubtful accounts | $ 27 | $ 18 |
Preferred stock, shares authorized (in shares) | 20,000,000 | 20,000,000 |
Common stock, par value (in dollars per share) | $ 0 | $ 0 |
Common stock, shares authorized (in shares) | 150,000,000 | 150,000,000 |
Common stock, shares issued (in shares) | 6,309,509 | 5,158,967 |
Common stock, shares outstanding (in shares) | 6,309,509 | 5,158,967 |
Series G Preferred Stock [Member] | ||
Preferred stock, shares authorized (in shares) | 3,000 | 3,000 |
Preferred stock, stated value (in dollars per share) | $ 150 | $ 150 |
Preferred stock, shares issued (in shares) | 150 | 150 |
Preferred stock, shares outstanding (in shares) | 150 | 150 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues | $ 41,617 | $ 31,131 |
Cost of goods sold | 42,376 | 30,689 |
Gross profit (loss) | (759) | 442 |
Selling, general and administrative expenses | 6,690 | 7,087 |
Impairment of goodwill | 0 | 3,915 |
Loss (gain) on disposition and involuntary conversion of property and equipment | (147) | 6 |
Operating loss | (7,302) | (10,566) |
Other income (expense): | ||
Interest expense | (572) | (463) |
Interest income | 22 | 1 |
Change in fair value of derivative warrant liability | 189 | 389 |
Gain on extinguishment of PPP Loan | 0 | 1,792 |
Other income | 7 | 4 |
Other expense | (183) | (85) |
Loss before income taxes | (7,839) | (8,928) |
Income tax expense | (19) | (21) |
Net loss | $ (7,858) | $ (8,949) |
Loss per common share: | ||
Basic (in dollars per share) | $ (1.42) | $ (1.87) |
Diluted (in dollars per share) | $ (1.42) | $ (1.87) |
Weighted average number of shares outstanding: | ||
Basic (in shares) | 5,514,671 | 4,773,895 |
Diluted (in shares) | 5,514,671 | 4,773,895 |
Consolidated Statements of Chan
Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands | Stock Units Issued (SUI) [Member] Preferred Stock [Member] | Stock Units Issued (SUI) [Member] Common Stock [Member] | Stock Units Issued (SUI) [Member] Retained Earnings [Member] | Stock Units Issued (SUI) [Member] | Preferred Stock [Member] | Common Stock [Member] | Retained Earnings [Member] | Total |
Balance (in shares) at Dec. 31, 2020 | 225 | 4,523,809 | ||||||
Balance at Dec. 31, 2020 | $ 112 | $ 322,218 | $ (298,910) | $ 23,420 | ||||
Sales of common stock, net of costs (in shares) | 306,240 | |||||||
Sales of common stock, net of costs | $ 0 | $ 2,721 | 0 | 2,721 | ||||
Common stock awards under equity incentive plans (in shares) | 0 | 70,858 | ||||||
Common stock awards under equity incentive plans | $ 0 | $ 1,114 | 0 | 1,114 | ||||
Exercise of common stock warrants (in shares) | 0 | 248,543 | ||||||
Exercise of common stock warrants | $ 0 | $ 171 | 0 | 171 | ||||
Common stock issued to vendors (in shares) | 0 | 2,400 | ||||||
Common stock issued to vendors | $ 0 | $ 18 | 0 | 18 | ||||
Conversion of preferred stock into common stock (in shares) | (75) | 7,117 | ||||||
Conversion of preferred stock into common stock | $ (37) | $ 37 | 0 | 0 | ||||
Net loss | $ 0 | $ 0 | (8,949) | (8,949) | ||||
Balance (in shares) at Dec. 31, 2021 | 150 | 5,158,967 | ||||||
Balance at Dec. 31, 2021 | $ 75 | $ 326,279 | (307,859) | 18,495 | ||||
Common stock awards under equity incentive plans (in shares) | 0 | 137,695 | ||||||
Common stock awards under equity incentive plans | $ 0 | $ 1,261 | 0 | 1,261 | ||||
Exercise of common stock warrants (in shares) | 0 | 325,000 | ||||||
Exercise of common stock warrants | $ 0 | $ 0 | 0 | 0 | ||||
Common stock issued to vendors (in shares) | 0 | 0 | 0 | 2,400 | ||||
Common stock issued to vendors | $ 0 | $ 15 | $ 0 | $ 15 | $ 0 | $ 10 | 0 | 10 |
Net loss | $ 0 | $ 0 | (7,858) | (7,858) | ||||
Sales of common stock and common stock warrants, net of costs (in shares) | 0 | 675,000 | ||||||
Sales of common stock and common stock warrants, net of costs | $ 0 | $ 986 | 0 | 986 | ||||
Other (in shares) | 0 | 10,447 | ||||||
Balance (in shares) at Dec. 31, 2022 | 150 | 6,309,509 | ||||||
Balance at Dec. 31, 2022 | $ 75 | $ 328,551 | $ (315,717) | $ 12,909 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Cash flow from operating activities: | ||
Net loss | $ (7,858) | $ (8,949) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation | 2,103 | 2,397 |
Amortization | 147 | 195 |
Stock and share-based compensation | 1,286 | 1,132 |
Change in fair value of derivative warrant liability | (189) | (389) |
Impairment of goodwill | 0 | 3,915 |
Loss (gain) on disposition and involuntary conversion of property and equipment | (147) | 6 |
Gain on extinguishment of PPP loan | 0 | (1,792) |
Provision for bad debts | 64 | 15 |
Accretion of interest | 24 | 83 |
Other | (33) | 0 |
Changes in operating assets and liabilities: | ||
Accounts receivable | 369 | (1,332) |
Inventories | 66 | (566) |
Accounts payable and accrued expenses | 624 | 280 |
Commodities payable | (156) | 876 |
Other | (236) | (69) |
Net cash used in operating activities | (3,936) | (4,198) |
Cash flows from investing activities: | ||
Purchases of property and equipment | (563) | (1,440) |
Proceeds from insurance on involuntary conversion | 109 | 639 |
Proceeds from sale of property and equipment | 0 | 3 |
Net cash used in investing activities | (454) | (798) |
Cash flows from financing activities: | ||
Advances on factoring agreement | 38,117 | 31,038 |
Payments on bank line of credit | (2,035) | 0 |
Advances on insurance premium finance agreements | 927 | 962 |
Payments on insurance premium finance agreements | (870) | (960) |
Advances on long-term debt, net of issuance costs | 900 | 1,167 |
Payments of long-term debt and finance lease liabilities | (1,310) | (665) |
Proceeds from issuances of common stock and warrants, net of cash issuance costs | 1,256 | 3,364 |
Proceeds from common stock warrant exercises | 0 | 171 |
Net cash provided by financing activities | 2,506 | 5,558 |
Net change in cash and cash equivalents | (1,884) | 562 |
Cash and cash equivalents, beginning of period | 5,825 | 5,263 |
Cash and cash equivalents, end of period | 3,941 | 5,825 |
Net change in cash and cash equivalents and restricted cash | (1,884) | 562 |
Supplemental disclosures: | ||
Cash paid for interest | 548 | 354 |
Cash paid for income taxes | 26 | 18 |
Factoring Agreement [Member] | ||
Cash flows from financing activities: | ||
Payments on factoring agreement | (38,346) | (29,519) |
Line of Credit With Bank [Member] | ||
Cash flows from financing activities: | ||
Advances on factoring agreement | $ 3,867 | $ 0 |
Note 1 - Liquidity and Manageme
Note 1 - Liquidity and Management's Plan | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Substantial Doubt about Going Concern [Text Block] | NOTE 1. ’ S PLAN Our multi-year history of operating losses and negative operating cash flows from continuing operations raised substantial doubt about our ability to continue as a going concern before consideration of management’s plans, however after consideration of management’s plans and the factors below, we believe substantial doubt about our ability to continue as a going concern within one Cash Reserves December 31, 2022, Improving Operating Cash Flows 2023 two 2022 October 1, 2022, 2022. 2018, first fourth 2022 2019, fourth 2022 third 2022. 2023. Access to Equity Funding 10 September 2023. 2022 2021 10. Ability to Leverage and/or Sell Real Property no Strategic Review Process 2022, |
Note 2 - Business and Summary o
Note 2 - Business and Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] | NOTE 2. Business We are a specialty ingredient company focused on the development, production, and marketing of products derived from traditional and ancient small grains. We create and produce products utilizing proprietary processes to deliver improved nutrition, ease of use, and extended shelf-life, while addressing consumer demand for all natural, non-GMO and organic products. Notably, we convert raw rice bran into stabilized rice bran (SRB), and high value-added derivative products including: RiBalance, a rice bran nutritional package derived from SRB; RiSolubles, a nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a fiber rich insoluble derivative of RiBalance and ProRyza, a rice bran protein-based product. SRB is an additive used in human and animal foods. SRB has certain attractions compared to additives based on the by-products of other agricultural commodities, such as corn, soybeans, wheat, and yeast. Our SRB and SRB derivatives are healthy, natural, hypoallergenic, gluten free, and non-genetically modified ingredients used in a variety of applications. We produce SRB from four locations: two facilities located within supplier-owned rice mills in California; and two company-owned facility in the Louisiana and Arkansas delta region. We produce SRB derivatives at our Dillon, Montana, facility and we operate two Segment Reporting Given the integrated nature of the products we produce and the facilities in which we produce them, we have one reporting unit and one Recent Accounting Guidance Recent accounting standards not The following discusses the accounting standard(s) not In June 2016, ASU No. 2016 13 Financial Instruments Credit Losses (Topic 326 Measurement of Credit Losses on Financial Instruments 2023 January 1, 2023. not Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation Use of Estimates Reclassifications no Cash and Cash Equivalents three may not not Accounts Receivable and Allowance for Doubtful Accounts may not Inventories Property and Equipment Impairment of Long-lived Assets may not not Intangible Assets may not may not not Leases We recognize right-of-use assets and lease liabilities based on the present value of the future minimum lease payments over the lease term, beginning at the commencement date, for leases exceeding a year. Minimum lease payments include the fixed lease components of the lease and any variable rate payments that depend on an index, initially measured using the index at the lease commencement date. Lease terms may In determining our right-of-use assets and lease liabilities, we apply a discount rate to the minimum lease payments within each lease. When we cannot readily determine the discount rate implicit in a lease, we utilize our incremental borrowing rate, the rate of interest that we would incur to borrow, on a collateralized basis over a similar term, an amount equal to the lease payments in a similar economic environment. To estimate the incremental borrowing rate, we reference a market yield curve consistent with our assessment of our credit quality. We recognize operating lease expense related to the minimum lease payments on a straight-line basis over the lease term. For finance leases, we recognize amortization expense related to the minimum lease payments on a straight-line basis over the lease term while interest expense is recognized using the effective interest method. Expense related to variable lease payments that do not Revenue Recognition We measure revenue as the amount of consideration we expect to receive in exchange for fulfilling product orders. Incidental items that are immaterial in the context of the contract are recognized as expense. Our contracts do not may We capitalize the incremental costs of obtaining a revenue contract and amortized those costs on a straight-line basis over the expected customer relationship period if we expect to recover those costs. As a practical expedient, we expense costs to obtain a contract as incurred if the amortization period would have been a year or less. Typically, costs to incur revenue contracts are not Selling, General and Administrative Expenses Share-Based Compensation no We have outstanding common stock options as of December 31, 2022 2021. not 2020. We recognize forfeitures of employee and director awards as they occur. In the event an employee or director terminates service prior to the vesting of an award, we reverse the entire amount of previously recognized compensation expense related to the award. Share-based compensation for awards to nonemployees is calculated as of the grant date, taking into consideration the probability of satisfaction of performance conditions, in a manner consistent with awards to employees. The expense associated with share-based awards for service is recognized over the term of service. In the event services are terminated early or we require no Income Taxes We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable income in the years in which temporary differences are expected to be recovered or settled. We recognized deferred tax assets for deductible temporary differences and operating loss and tax credit carryforwards. When necessary, we establish a valuation allowance to reduce that deferred tax asset if it is more likely than not not may may may may no We recognize interest and penalties related to uncertain tax positions, if any, in selling, general and administrative expenses. Derivative Warrant Liability Fair Value may may We assess the inputs used to measure fair value using a three ● Level 1 ● Level 2 ● Level 3 not |
Note 3 - Cash and Cash Equivale
Note 3 - Cash and Cash Equivalents | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Cash and Cash Equivalents Disclosure [Text Block] | NOTE 3. As of December 31, 2022, three We have cash on deposit in excess of federally insured limits at a bank. We do not |
Note 4 - Accounts Receivable an
Note 4 - Accounts Receivable and Revenues | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Accounts Receivable and Revenues [Text Block} | NOTE 4. We classify amounts billed as accounts receivable on our consolidated balance sheets and require payment on a short-term basis. Invoices are generally issued at the point control transfers and substantially all of our invoices are due within 30 120 30 2022 2021 Our accounts receivable potentially subject us to significant concentrations of credit risk. Revenues and accounts receivable from significant customers (customers with revenue or accounts receivable in excess of 10% Customer A B C % of revenue, 2022 14.0 % 8.5 % 6.8 % % of revenue, 2021 11.9 % 0.3 % 11.4 % % of accounts receivable, as of December 31, 2022 11.6 % 18.6 % 0.2 % % of accounts receivable, as of December 31, 2021 17.2 % 0.0 % 9.0 % The following table presents revenues by geographic area shipped to (in thousands). 2022 2021 United States $ 40,267 $ 29,637 Other countries 1,350 1,494 Revenues $ 41,617 $ 31,131 |
Note 5 - Inventories
Note 5 - Inventories | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Inventory Disclosure [Text Block] | NOTE 5. The following table details the components of inventories (in thousands). December 31 2022 2021 Finished goods $ 1,737 $ 1,560 Raw materials 423 718 Packaging 218 166 Inventories $ 2,378 $ 2,444 |
Note 6 - Property and Equipment
Note 6 - Property and Equipment | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Property, Plant and Equipment Disclosure [Text Block] | NOTE 6. The following table details the components of property and equipment (amounts in thousands). December 31 2022 2021 Estimated Useful Lives (Years) Land $ 730 $ 730 Furniture and fixtures 259 265 5 - 10 Plant 10,095 10,457 20 - 40 or life of lease Computer and software 450 452 3 - 5 Leasehold improvements 1,838 1,828 4 - 15 or life of lease Machinery and equipment 15,703 15,115 5 - 15 Property and equipment, cost 29,075 28,847 Less accumulated depreciation 14,868 13,403 Property and equipment, net $ 14,207 $ 15,444 Amounts payable for property and equipment included in accounts payable totaled $0.1 million at December 31, 2022, December 31, 2021. not December 31, 2022, December 31, 2021. |
Note 7 - Intangible Assets and
Note 7 - Intangible Assets and Goodwill | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Goodwill and Intangible Assets Disclosure [Text Block] | NOTE 7. Intangible assets, excluding goodwill, consist of the following (in thousands). December 31, 2022 December 31, 2021 Estimated Useful Life Gross Carrying Value Accumulated Amortization Net Carrying Value Gross Carrying Value Accumulated Amortization Net Carrying Value Customer relationships 15 $ 930 $ 564 $ 366 $ 930 $ 423 $ 507 Trademarks 10 13 5 8 13 3 10 Non-compete agreement 5 22 16 6 22 12 10 Total intangible assets $ 965 $ 585 $ 380 $ 965 $ 438 $ 527 The customer relationship intangible is amortizing over the 15-year period of expected future economic benefit, in proportion to the discounted expected future cash flows used to estimate the value of the intangible at acquisition in 2019. As of December 31, 2022, 2023 $ 111 2024 80 2025 58 2026 42 2027 31 Thereafter 58 Total amortization $ 380 We performed our annual impairment testing of goodwill as of December 31, 2021. 2021, |
Note 8 - Leases
Note 8 - Leases | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Lessee, Operating and Finance Leases [Text Block] | NOTE 8. The components of lease expense and cash flows from leases (in thousands) follow. 2022 2021 Finance lease cost: Amortization of right-of use assets, included in cost of goods sold $ 97 $ 89 Interest on lease liabilities 21 11 Operating lease cost, included in selling, general and administrative expenses: Fixed leases cost 515 515 Variable lease cost 168 149 Short-term lease cost 85 61 Total lease cost $ 886 $ 825 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from finance leases $ 21 $ 11 Operating cash flows from operating leases $ 515 $ 515 Financing cash flows from finance leases $ 104 $ 96 As of December 31, 2022, not December 31, 2022, 2022, 2021, As of December 31, 2022, not December 31, 2022, Operating Leases Finance Leases Remaining leases terms (in years) 0.8 - 10.2 0.3 - 4.8 Weighted average remaining lease terms (in years) 5.5 4.0 Discount rates 6.3% - 9.0% 2.8% - 10.4% Weighted average discount rate 7.8% 8.2% As of December 31, 2022, 2032. December 31, 2022, Operating Finance Leases Leases 2023 $ 528 $ 158 2024 429 117 2025 439 102 2026 451 99 2027 232 60 Thereafter 346 - Total lease payments 2,425 536 Amounts representing interest (477 ) (86 ) Present value of lease obligations $ 1,948 $ 450 |
Note 9 - Debt
Note 9 - Debt | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Debt Disclosure [Text Block] | NOTE 9. We finance certain amounts owed for annual insurance premiums under financing agreements. As of December 31, 2022, March 31, 2023, We also borrow under a factoring agreement with a lender (the Lender), which provides a $7.0 million credit facility. We may two October 2023. no The Lender advanced us $0.9 million effective September 30, 2022 ( December 31 2022). January 2023. December 31, 2022, January 2023, Additional information related to our factoring obligation (exclusive of the Over-advance) follows. 2022 2021 Average borrowings outstanding (in thousands) $ 3,179 $ 1,622 Amortization of debt issuance costs (in thousands) $ - $ 75 Fees paid, as a percentage of average outstanding borrowings 5.8 % 6.2 % Interest paid, as a percentage of average outstanding borrowings 7.0 % 6.4 % Long-term debt consists of the following (in thousands). December 31, 2022 2021 Mortgage promissory note - Originally dated July 2020 and modified in December 2021 and January 2023. As modified, interest accrues at an annual rate which is the greater of 7.0 14.5 10.3 January 2025 2.5 $ 2,211 $ 2,469 Progress payment agreement - Dated August 2022. Original principal $ 37 25.2 39 - Equipment note - Dated May 2021. Original principal $ 46 June 2025 3.6 24 33 Equipment note - Dated December 2019. Original principal $ 40 December 2024 9.3 18 26 Other 11 Total long-term debt, net $ 2,292 $ 2,539 In December 2021, no 1ender’s May 2022 June 2022. December 2021 January 2023. In January 2023, December 2021 December 2021 January 2023 1ender’s January 2025. December 31, 2022, January 2023 Future principal maturities of long-term debt outstanding at December 31, 2022, January 2023 2023 $ 996 2024 1,194 2025 111 Principal maturities 2,301 Debt issuance costs (9 ) Total long-term debt, net $ 2,292 |
Note 10 - Equity, Share-based C
Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Shareholders' Equity and Share-Based Payments [Text Block] | NOTE 10. In August 2022, 1 10 August 26, 2022. Preferred Stock Our board of directors, without further action or vote by holders of our common stock, has the right to establish the terms, preference, rights and restrictions and issue shares of preferred stock. We previously designated and issued six seventh December 31, 2022. The Series G preferred stock is non-voting and may 1 Securities Offerings In October 2022, 2022 3. 2022 2022. April 2023, October 2025. December 31, 2022, 2022 October 20, 2022, October 2022 may October 2027. In September 2021, 2021 3. September 2022, September 2023, 5 2021 2021, 2021 not may September 13, 2021, 230,786 2021 September 13, 2021, September 2021 On March 30, 2020, 3. 2021, 2021 Under the terms of the securities purchase agreement related to the September 2021 September 13, 2023. October May 20, 2023, October 20, 2023. Equity Incentive Plan Our board of directors adopted our Amended and Restated 2014 2014 July 14, 2022, 2014 2014 may may 2014 4 5 December 31, 2022, 2014 Share-based compensation expenses related to employees and directors are included in selling, general and administrative expenses. Share-based compensation by type of award follows (in thousands). 2022 2021 Restricted stock units $ 1,160 $ 866 Stock options 101 140 Common stock - 108 Compensation expense related to common stock awards issued under equity incentive plan $ 1,261 $ 1,114 Information regarding common stock issued under the 2014 2022 2021 2022 2021 Shares Issued Weighted Average Grant Date Fair Value Per Share Shares Issued Weighted Average Grant Date Fair Value Per Share Directors 34,875 $ 6.71 13,608 $ 7.95 Employees 89,307 5.75 57,250 5.52 Consultant 13,516 6.47 - 137,698 70,858 In the period from January1, 2023 March 16, 2023, Restricted Stock Units We have outstanding (i) restricted stock units issued under the 2014 one RSUs SUs Number of Units Unrecognized Compensation (in thousands) Average Grant Date Fair Value per share Weighted Average Expense Period ( Years) Number of Units Unrecognized Compensation (in thousands) Average Grant Date Fair Value per share Weighted Average Expense Period (Years) Nonvested at January 1, 2021 149,540 $ 730 $ 4.88 1.4 - $ - $ - $ - Granted 82,469 796 9.65 1.0 - - - - Forfeited (291 ) (3 ) 10.31 0.7 - - - - Vested with service (105,115 ) - - - - - - Expensed - (865 ) NA - - - - - Nonvested at December 31, 2021 126,603 658 5.20 0.9 - - - - Granted 527,871 1,680 3.18 2.7 160,000 216 1.35 3.0 Impact of Modification: - - - - Before modification (17,050 ) (150 ) 8.77 0.6 - - - - After modification 17,050 64 3.73 - - - - - Forfeited (11,744 ) (68 ) 5.77 1.1 - - - - Vested with Service (275,912 ) - - - - - - Expensed - (1,160 ) NA - - (15 ) NA - Nonvested at December 31, 2022 366,818 $ 1,024 $ 2.79 2.8 160,000 $ 201 $ 1.26 2.7 Number of RSUs Vested at January 1, 2021 38,640 Vested with service 105,115 Issued at vesting (57,250 ) Vested at December 31, 2021 86,505 Vested with service 275,912 Issued at vesting (83,725 ) Issued at termination of service (53,967 ) Vested at December 31, 2022 224,725 At December 31, 2022, December 31, 2022, December 31, 2022, no We issued 160,000 SUs to a service provider in 2022, three September 2025 three may October 1, 2022, may 90 160,000 2022 may not In 2022, Options As of December 31, 2022 2021, no 2022 2021. 2022 2021. December 31, 2022, December 31, 2022, December 31, 2022, Unrecognized Compensation As of December 31, 2022, Warrants The 2022 2022 2021 2021 September 2022, September 2023, 5 Warrant activity, excluding activity related to prefunded warrants follows. 2022 2021 Shares Under Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Shares Under Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Outstanding at January 1 875,067 $ 9.76 1.4 664,592 $ 9.82 1.1 Issued 2,063,000 1.61 3.1 230,769 $ 10.00 5.0 Impact of Warrant A exercise price adjustment: Before adjustment 230,769 10.00 4.0 After adjustment (230,769 ) 2.72 4.0 Cash exercised (17,794 ) 9.60 0.8 Expired (639,298 ) 9.60 - (2,500 ) 52.50 - Outstanding at December 31 2,298,769 $ 1.76 2.9 875,067 $ 9.76 1.4 The following table summarizes information related to exercisable and outstanding warrants as of December 31, 2022. Outstanding Exercisable Exercise Prices Shares Under Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Shares Under Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) $ 1.60 2,000,000 $ 1.60 2.8 - $ - - $ 1.88 63,000 1.88 4.8 - - - $ 2.72 230,769 2.72 3.7 230,769 2.72 3.7 $ 20.00 5,000 20.00 0.1 5,000 20.00 0.1 2,298,769 $ 1.76 2.9 235,769 $ 3.09 3.6 |
Note 11 - Income Taxes
Note 11 - Income Taxes | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Income Tax Disclosure [Text Block] | NOTE 11. Deferred tax asset (liability) is comprised of the following (in thousands): December 31 2022 2021 Net operating loss carryforwards $ 14,264 $ 13,385 Stock options and warrants 1,151 832 Property and equipment (46 ) 16 Intangible assets 875 950 Capitalized expenses 117 105 Other 655 64 Operating right-of-use lease assets (478 ) (566 ) Operating right-of-use lease liabilities 645 670 Net deferred tax assets 17,183 15,456 Less: Valuation allowance (17,183 ) (15,456 ) Deferred tax asset (liability) $ - $ - We have determined it is more likely than not not The following table summarizes the change in the valuation allowance (in thousands): 2022 2021 Valuation allowances, beginning of year $ 15,456 $ 12,421 Net operating loss and other temporary differences 1,997 2,926 Expiration of net operating losses and limitations (90 ) - Adjustment to deferred taxes (197 ) 67 Impact of state tax rate change 22 42 Other (5 ) - Valuation allowance, end of year $ 17,183 $ 15,456 As of December 31, 2022, December 31, 2017, not 2023 2037 not December 31, 2022, 2023 2042. Our ability to utilize previously accumulated NOL carryforwards is subject to substantial annual limitations due to the changes in ownership provisions of the Internal Revenue Code (IRC) of 1986, 2020, 382 may We are subject to taxation in the U.S. federal jurisdiction and various state and local jurisdictions. We record liabilities for income tax contingencies based on our best estimate of the underlying exposures. We are open for audit by the IRS for years after 2018 2017. Reconciliations between the amounts computed by applying the U.S. federal statutory tax rate to loss before income taxes, and income tax expense (benefit) follows (in thousands): 2022 2021 Income tax benefit at federal statutory rate $ (1,646 ) $ (1,875 ) Increase (decrease) resulting from: State tax benefit, net of federal tax effect (421 ) (605 ) Effect of change in state tax rate (22 ) (42 ) Change in valuation allowance 1,727 3,035 Expirations of net operating losses and application of IRC 382 limitation 90 - PPP loan forgiveness, nontaxable - (376 ) Change in fair value of derivative warrant liability, nontaxable 5 (81 ) Other nondeductible expenses 89 32 Adjustments to deferreds 197 (67 ) Income tax expense $ 19 $ 21 Based on an analysis of tax positions taken on income tax returns filed, we determined no December 31, 2022 2021. may |
Note 12 - Income (Loss) Per Sha
Note 12 - Income (Loss) Per Share (EPS) | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Earnings Per Share [Text Block] | NOTE 12. Basic EPS is calculated under the two may not Diluted EPS is computed by dividing the net income attributable to RiceBran Technologies common shareholders by the weighted average number of common shares outstanding during the period increased by the number of additional common shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive. The dilutive effects of outstanding options, warrants, nonvested shares of common stock and nonvested restricted stock units that vest solely on the basis of a service condition are calculated using the treasury stock method. The dilutive effects of the outstanding preferred stock are calculated using the if-converted method. Below are reconciliations of the numerators and denominators in the EPS computations. 2022 2021 NUMERATOR (in thousands): Basic and diluted - net loss $ (7,858 ) $ (8,949 ) DENOMINATOR: Weighted average number of shares of shares of common stock outstanding 5,414,079 4,710,567 Weighted average number of shares of common stock underlying vested restricted stock units 100,592 63,328 Basic EPS - weighted average number of shares outstanding 5,514,671 4,773,895 Effect of dilutive securities outstanding - - Diluted EPS - weighted average number of shares outstanding 5,514,671 4,773,895 No 2022 2021, 2022 2021 10, |
Note 13 - Fair Value Measuremen
Note 13 - Fair Value Measurements | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Fair Value Disclosures [Text Block] | NOTE 13. The fair value of cash and cash equivalents, restricted cash, accounts and other receivables, accounts payable, commodities payable and short-term debt approximated their carrying value due to shorter maturities. As of December 31, 2022, 3 December 31, 2022, 3 The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our consolidated balance sheets (in thousands): Level 1 Level 2 Level 3 Total As of December 31, 2022: Derivative warrant liability $ - $ - $ 69 $ 69 Total liabilities at fair value $ - $ - $ 69 $ 69 As of December 31, 2021: Derivative warrant liability $ - $ - $ 258 $ 258 Total liabilities at fair value $ - $ - $ 258 $ 258 The following tables summarize the changes in level 3 Fair Value as of Beginning of Period Total Realized and Unrealized Gains (Losses) Issuance of New Instruments Net Transfers (Into) Out of Level 3 Fair Value, at End of Period Change in Unrealized Gains (Losses) on Instruments Still Held 2022: Derivative warrant liability $ 258 $ (189 ) $ - $ - $ 69 $ (189 ) Total Level 3 fair value $ 258 $ (189 ) $ - $ - $ 69 $ (189 ) 2021: Derivative warrant liability $ - $ - $ 647 $ - $ 258 $ (389 ) Total Level 3 fair value $ - $ - $ 647 $ - $ 258 $ (389 ) The derivative warrant liability in the tables above relates to Warrant A, discussed further in Note 10. may December 31, 2022 December 31, 2021 September 30, 2021 Assumed exercise price, per share $ 2.72 $ 10.00 $ 10.00 Assumed volatility 92.2 % 69.5 % 71.0 % Assumed risk free interest rate 4.3 % 0.8 % 0.4 % Expected life of options (in years) 4.0 4.8 5.0 Expected dividends - - - The fair value of Warrant A approximates the cash settlement the holder could elect to be paid in the event of a change in control. At December 31, 2022, |
Note 14 - Commitments and Conti
Note 14 - Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Commitments and Contingencies Disclosure [Text Block] | NOTE 14. PPP Audit Contingency In April 2020, March 2020. January 2021. may January 2027, six may 2020 $2 Employment Contracts and Severance Payments In the normal course of business, we periodically enter into employment agreements which incorporate indemnification provisions. While the maximum amount to which we may No We have employment contracts with certain officers and key management that include provisions for potential severance payments in the event of without-cause terminations or terminations under certain circumstances after a change in control. In addition, vesting of outstanding nonvested equity grants would accelerate following a change in control. Legal Matters From time to time, we are involved in litigation incidental to the conduct of our business. These matters may no 2022 2021. In January 2023, 2012. |
Significant Accounting Policies
Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Segment Reporting, Policy [Policy Text Block] | Segment Reporting Given the integrated nature of the products we produce and the facilities in which we produce them, we have one reporting unit and one |
New Accounting Pronouncements, Policy [Policy Text Block] | Recent Accounting Guidance Recent accounting standards not The following discusses the accounting standard(s) not In June 2016, ASU No. 2016 13 Financial Instruments Credit Losses (Topic 326 Measurement of Credit Losses on Financial Instruments 2023 January 1, 2023. not |
Consolidation, Policy [Policy Text Block] | Basis of Presentation and Principles of Consolidation |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates |
Reclassification, Comparability Adjustment [Policy Text Block] | Reclassifications no |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and Cash Equivalents three may not not |
Accounts Receivable [Policy Text Block] | Accounts Receivable and Allowance for Doubtful Accounts may not |
Inventory, Policy [Policy Text Block] | Inventories |
Property, Plant and Equipment, Policy [Policy Text Block] | Property and Equipment |
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] | Impairment of Long-lived Assets may not not |
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] | Intangible Assets may not may not not |
Lessee, Leases [Policy Text Block] | Leases We recognize right-of-use assets and lease liabilities based on the present value of the future minimum lease payments over the lease term, beginning at the commencement date, for leases exceeding a year. Minimum lease payments include the fixed lease components of the lease and any variable rate payments that depend on an index, initially measured using the index at the lease commencement date. Lease terms may In determining our right-of-use assets and lease liabilities, we apply a discount rate to the minimum lease payments within each lease. When we cannot readily determine the discount rate implicit in a lease, we utilize our incremental borrowing rate, the rate of interest that we would incur to borrow, on a collateralized basis over a similar term, an amount equal to the lease payments in a similar economic environment. To estimate the incremental borrowing rate, we reference a market yield curve consistent with our assessment of our credit quality. We recognize operating lease expense related to the minimum lease payments on a straight-line basis over the lease term. For finance leases, we recognize amortization expense related to the minimum lease payments on a straight-line basis over the lease term while interest expense is recognized using the effective interest method. Expense related to variable lease payments that do not |
Revenue from Contract with Customer [Policy Text Block] | Revenue Recognition We measure revenue as the amount of consideration we expect to receive in exchange for fulfilling product orders. Incidental items that are immaterial in the context of the contract are recognized as expense. Our contracts do not may We capitalize the incremental costs of obtaining a revenue contract and amortized those costs on a straight-line basis over the expected customer relationship period if we expect to recover those costs. As a practical expedient, we expense costs to obtain a contract as incurred if the amortization period would have been a year or less. Typically, costs to incur revenue contracts are not |
Selling, General and Administrative Expenses, Policy [Policy Text Block] | Selling, General and Administrative Expenses |
Share-Based Payment Arrangement, Director [Policy Text Block] | Share-Based Compensation no We have outstanding common stock options as of December 31, 2022 2021. not 2020. We recognize forfeitures of employee and director awards as they occur. In the event an employee or director terminates service prior to the vesting of an award, we reverse the entire amount of previously recognized compensation expense related to the award. Share-based compensation for awards to nonemployees is calculated as of the grant date, taking into consideration the probability of satisfaction of performance conditions, in a manner consistent with awards to employees. The expense associated with share-based awards for service is recognized over the term of service. In the event services are terminated early or we require no |
Income Tax, Policy [Policy Text Block] | Income Taxes We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable income in the years in which temporary differences are expected to be recovered or settled. We recognized deferred tax assets for deductible temporary differences and operating loss and tax credit carryforwards. When necessary, we establish a valuation allowance to reduce that deferred tax asset if it is more likely than not not may may may may no We recognize interest and penalties related to uncertain tax positions, if any, in selling, general and administrative expenses. |
Derivatives, Policy [Policy Text Block] | Derivative Warrant Liability |
Fair Value Measurement, Policy [Policy Text Block] | Fair Value may may We assess the inputs used to measure fair value using a three ● Level 1 ● Level 2 ● Level 3 not |
Note 4 - Accounts Receivable _2
Note 4 - Accounts Receivable and Revenues (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Schedules of Concentration of Risk, by Risk Factor [Table Text Block] | Customer A B C % of revenue, 2022 14.0 % 8.5 % 6.8 % % of revenue, 2021 11.9 % 0.3 % 11.4 % % of accounts receivable, as of December 31, 2022 11.6 % 18.6 % 0.2 % % of accounts receivable, as of December 31, 2021 17.2 % 0.0 % 9.0 % |
Disaggregation of Revenue [Table Text Block] | 2022 2021 United States $ 40,267 $ 29,637 Other countries 1,350 1,494 Revenues $ 41,617 $ 31,131 |
Note 5 - Inventories (Tables)
Note 5 - Inventories (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Schedule of Inventory, Current [Table Text Block] | December 31 2022 2021 Finished goods $ 1,737 $ 1,560 Raw materials 423 718 Packaging 218 166 Inventories $ 2,378 $ 2,444 |
Note 6 - Property and Equipme_2
Note 6 - Property and Equipment (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Property, Plant and Equipment [Table Text Block] | December 31 2022 2021 Estimated Useful Lives (Years) Land $ 730 $ 730 Furniture and fixtures 259 265 5 - 10 Plant 10,095 10,457 20 - 40 or life of lease Computer and software 450 452 3 - 5 Leasehold improvements 1,838 1,828 4 - 15 or life of lease Machinery and equipment 15,703 15,115 5 - 15 Property and equipment, cost 29,075 28,847 Less accumulated depreciation 14,868 13,403 Property and equipment, net $ 14,207 $ 15,444 |
Note 7 - Intangible Assets an_2
Note 7 - Intangible Assets and Goodwill (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Schedule of Finite-Lived Intangible Assets [Table Text Block] | December 31, 2022 December 31, 2021 Estimated Useful Life Gross Carrying Value Accumulated Amortization Net Carrying Value Gross Carrying Value Accumulated Amortization Net Carrying Value Customer relationships 15 $ 930 $ 564 $ 366 $ 930 $ 423 $ 507 Trademarks 10 13 5 8 13 3 10 Non-compete agreement 5 22 16 6 22 12 10 Total intangible assets $ 965 $ 585 $ 380 $ 965 $ 438 $ 527 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] | 2023 $ 111 2024 80 2025 58 2026 42 2027 31 Thereafter 58 Total amortization $ 380 |
Note 8 - Leases (Tables)
Note 8 - Leases (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Lease, Cost [Table Text Block] | 2022 2021 Finance lease cost: Amortization of right-of use assets, included in cost of goods sold $ 97 $ 89 Interest on lease liabilities 21 11 Operating lease cost, included in selling, general and administrative expenses: Fixed leases cost 515 515 Variable lease cost 168 149 Short-term lease cost 85 61 Total lease cost $ 886 $ 825 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from finance leases $ 21 $ 11 Operating cash flows from operating leases $ 515 $ 515 Financing cash flows from finance leases $ 104 $ 96 |
Lessee, Operating and Finance Leases, Remaining Terms and Discount Rates [Table Text Block] | Operating Leases Finance Leases Remaining leases terms (in years) 0.8 - 10.2 0.3 - 4.8 Weighted average remaining lease terms (in years) 5.5 4.0 Discount rates 6.3% - 9.0% 2.8% - 10.4% Weighted average discount rate 7.8% 8.2% |
Lessee, Operating and Finance Lease Liability, Maturity [Table Text Block] | Operating Finance Leases Leases 2023 $ 528 $ 158 2024 429 117 2025 439 102 2026 451 99 2027 232 60 Thereafter 346 - Total lease payments 2,425 536 Amounts representing interest (477 ) (86 ) Present value of lease obligations $ 1,948 $ 450 |
Note 9 - Debt (Tables)
Note 9 - Debt (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Schedule of Debt [Table Text Block] | 2022 2021 Average borrowings outstanding (in thousands) $ 3,179 $ 1,622 Amortization of debt issuance costs (in thousands) $ - $ 75 Fees paid, as a percentage of average outstanding borrowings 5.8 % 6.2 % Interest paid, as a percentage of average outstanding borrowings 7.0 % 6.4 % |
Schedule of Long-Term Debt Instruments [Table Text Block] | December 31, 2022 2021 Mortgage promissory note - Originally dated July 2020 and modified in December 2021 and January 2023. As modified, interest accrues at an annual rate which is the greater of 7.0 14.5 10.3 January 2025 2.5 $ 2,211 $ 2,469 Progress payment agreement - Dated August 2022. Original principal $ 37 25.2 39 - Equipment note - Dated May 2021. Original principal $ 46 June 2025 3.6 24 33 Equipment note - Dated December 2019. Original principal $ 40 December 2024 9.3 18 26 Other 11 Total long-term debt, net $ 2,292 $ 2,539 |
Schedule of Maturities of Long-Term Debt [Table Text Block] | 2023 $ 996 2024 1,194 2025 111 Principal maturities 2,301 Debt issuance costs (9 ) Total long-term debt, net $ 2,292 |
Note 10 - Equity, Share-based_2
Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] | 2022 2021 Restricted stock units $ 1,160 $ 866 Stock options 101 140 Common stock - 108 Compensation expense related to common stock awards issued under equity incentive plan $ 1,261 $ 1,114 |
Share-Based Payment Arrangement, Activity [Table Text Block] | 2022 2021 Shares Issued Weighted Average Grant Date Fair Value Per Share Shares Issued Weighted Average Grant Date Fair Value Per Share Directors 34,875 $ 6.71 13,608 $ 7.95 Employees 89,307 5.75 57,250 5.52 Consultant 13,516 6.47 - 137,698 70,858 |
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] | RSUs SUs Number of Units Unrecognized Compensation (in thousands) Average Grant Date Fair Value per share Weighted Average Expense Period ( Years) Number of Units Unrecognized Compensation (in thousands) Average Grant Date Fair Value per share Weighted Average Expense Period (Years) Nonvested at January 1, 2021 149,540 $ 730 $ 4.88 1.4 - $ - $ - $ - Granted 82,469 796 9.65 1.0 - - - - Forfeited (291 ) (3 ) 10.31 0.7 - - - - Vested with service (105,115 ) - - - - - - Expensed - (865 ) NA - - - - - Nonvested at December 31, 2021 126,603 658 5.20 0.9 - - - - Granted 527,871 1,680 3.18 2.7 160,000 216 1.35 3.0 Impact of Modification: - - - - Before modification (17,050 ) (150 ) 8.77 0.6 - - - - After modification 17,050 64 3.73 - - - - - Forfeited (11,744 ) (68 ) 5.77 1.1 - - - - Vested with Service (275,912 ) - - - - - - Expensed - (1,160 ) NA - - (15 ) NA - Nonvested at December 31, 2022 366,818 $ 1,024 $ 2.79 2.8 160,000 $ 201 $ 1.26 2.7 Number of RSUs Vested at January 1, 2021 38,640 Vested with service 105,115 Issued at vesting (57,250 ) Vested at December 31, 2021 86,505 Vested with service 275,912 Issued at vesting (83,725 ) Issued at termination of service (53,967 ) Vested at December 31, 2022 224,725 |
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | 2022 2021 Shares Under Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Shares Under Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Outstanding at January 1 875,067 $ 9.76 1.4 664,592 $ 9.82 1.1 Issued 2,063,000 1.61 3.1 230,769 $ 10.00 5.0 Impact of Warrant A exercise price adjustment: Before adjustment 230,769 10.00 4.0 After adjustment (230,769 ) 2.72 4.0 Cash exercised (17,794 ) 9.60 0.8 Expired (639,298 ) 9.60 - (2,500 ) 52.50 - Outstanding at December 31 2,298,769 $ 1.76 2.9 875,067 $ 9.76 1.4 |
Schedule of Share-based Compensation Warrants by Exercise Price Range [Table Text Block ] | Outstanding Exercisable Exercise Prices Shares Under Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Shares Under Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) $ 1.60 2,000,000 $ 1.60 2.8 - $ - - $ 1.88 63,000 1.88 4.8 - - - $ 2.72 230,769 2.72 3.7 230,769 2.72 3.7 $ 20.00 5,000 20.00 0.1 5,000 20.00 0.1 2,298,769 $ 1.76 2.9 235,769 $ 3.09 3.6 |
Note 11 - Income Taxes (Tables)
Note 11 - Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | December 31 2022 2021 Net operating loss carryforwards $ 14,264 $ 13,385 Stock options and warrants 1,151 832 Property and equipment (46 ) 16 Intangible assets 875 950 Capitalized expenses 117 105 Other 655 64 Operating right-of-use lease assets (478 ) (566 ) Operating right-of-use lease liabilities 645 670 Net deferred tax assets 17,183 15,456 Less: Valuation allowance (17,183 ) (15,456 ) Deferred tax asset (liability) $ - $ - |
Summary of Valuation Allowance [Table Text Block] | 2022 2021 Valuation allowances, beginning of year $ 15,456 $ 12,421 Net operating loss and other temporary differences 1,997 2,926 Expiration of net operating losses and limitations (90 ) - Adjustment to deferred taxes (197 ) 67 Impact of state tax rate change 22 42 Other (5 ) - Valuation allowance, end of year $ 17,183 $ 15,456 |
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] | 2022 2021 Income tax benefit at federal statutory rate $ (1,646 ) $ (1,875 ) Increase (decrease) resulting from: State tax benefit, net of federal tax effect (421 ) (605 ) Effect of change in state tax rate (22 ) (42 ) Change in valuation allowance 1,727 3,035 Expirations of net operating losses and application of IRC 382 limitation 90 - PPP loan forgiveness, nontaxable - (376 ) Change in fair value of derivative warrant liability, nontaxable 5 (81 ) Other nondeductible expenses 89 32 Adjustments to deferreds 197 (67 ) Income tax expense $ 19 $ 21 |
Note 12 - Income (Loss) Per S_2
Note 12 - Income (Loss) Per Share (EPS) (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | 2022 2021 NUMERATOR (in thousands): Basic and diluted - net loss $ (7,858 ) $ (8,949 ) DENOMINATOR: Weighted average number of shares of shares of common stock outstanding 5,414,079 4,710,567 Weighted average number of shares of common stock underlying vested restricted stock units 100,592 63,328 Basic EPS - weighted average number of shares outstanding 5,514,671 4,773,895 Effect of dilutive securities outstanding - - Diluted EPS - weighted average number of shares outstanding 5,514,671 4,773,895 |
Note 13 - Fair Value Measurem_2
Note 13 - Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] | Level 1 Level 2 Level 3 Total As of December 31, 2022: Derivative warrant liability $ - $ - $ 69 $ 69 Total liabilities at fair value $ - $ - $ 69 $ 69 As of December 31, 2021: Derivative warrant liability $ - $ - $ 258 $ 258 Total liabilities at fair value $ - $ - $ 258 $ 258 |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] | Fair Value as of Beginning of Period Total Realized and Unrealized Gains (Losses) Issuance of New Instruments Net Transfers (Into) Out of Level 3 Fair Value, at End of Period Change in Unrealized Gains (Losses) on Instruments Still Held 2022: Derivative warrant liability $ 258 $ (189 ) $ - $ - $ 69 $ (189 ) Total Level 3 fair value $ 258 $ (189 ) $ - $ - $ 69 $ (189 ) 2021: Derivative warrant liability $ - $ - $ 647 $ - $ 258 $ (389 ) Total Level 3 fair value $ - $ - $ 647 $ - $ 258 $ (389 ) |
Warrants, Valuation Assumption [Table Text Block] | December 31, 2022 December 31, 2021 September 30, 2021 Assumed exercise price, per share $ 2.72 $ 10.00 $ 10.00 Assumed volatility 92.2 % 69.5 % 71.0 % Assumed risk free interest rate 4.3 % 0.8 % 0.4 % Expected life of options (in years) 4.0 4.8 5.0 Expected dividends - - - |
Note 1 - Liquidity and Manage_2
Note 1 - Liquidity and Management's Plan (Details Textual) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Cash and Cash Equivalents, at Carrying Value, Total | $ 3,941 | $ 5,825 |
Note 2 - Business and Summary_2
Note 2 - Business and Summary of Significant Accounting Policies (Details Textual) | 12 Months Ended |
Dec. 31, 2022 | |
Number of Reporting Units | 1 |
Number of Operating Segments | 1 |
Stabilized Rice Bran (SRB) [Member] | |
Number of Manufacturing and Distribution Locations | 4 |
Stabilized Rice Bran (SRB) [Member] | CALIFORNIA | |
Number of Manufacturing and Distribution Locations | 2 |
Stabilized Rice Bran (SRB) [Member] | Louisiana and Arkansas Delta Region [Member] | |
Number of Manufacturing and Distribution Locations | 2 |
Note 3 - Cash and Cash Equiva_2
Note 3 - Cash and Cash Equivalents (Details Textual) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Cash and Cash Equivalents, at Carrying Value, Total | $ 3,941 | $ 5,825 |
Money Market Funds [Member] | ||
Cash and Cash Equivalents, at Carrying Value, Total | $ 2,700 |
Note 4 - Accounts Receivable _3
Note 4 - Accounts Receivable and Revenues (Details Textual) - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
Contract with Customer, Liability, Total | $ 0.1 | $ 0.1 |
Note 4 - Accounts Receivable _4
Note 4 - Accounts Receivable and Revenues - Revenues and Accounts Receivable from Significant Customers (Details) - Customer Concentration Risk [Member] | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Revenue Benchmark [Member] | Customer A [Member] | ||
Concentration risk, percentage | 14% | 11.90% |
Revenue Benchmark [Member] | Customer B [Member] | ||
Concentration risk, percentage | 8.50% | 0.30% |
Revenue Benchmark [Member] | Customer C [Member] | ||
Concentration risk, percentage | 6.80% | 11.40% |
Accounts Receivable [Member] | Customer A [Member] | ||
Concentration risk, percentage | 11.60% | 17.20% |
Accounts Receivable [Member] | Customer B [Member] | ||
Concentration risk, percentage | 18.60% | 0% |
Accounts Receivable [Member] | Customer C [Member] | ||
Concentration risk, percentage | 0.20% | 9% |
Note 4 - Accounts Receivable _5
Note 4 - Accounts Receivable and Revenues - Revenues by Product Line (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues | $ 41,617 | $ 31,131 |
UNITED STATES | ||
Revenues | 40,267 | 29,637 |
Other Countries [Member] | ||
Revenues | $ 1,350 | $ 1,494 |
Note 5 - Inventories - Componen
Note 5 - Inventories - Components of Inventories (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Finished goods | $ 1,737 | $ 1,560 |
Raw materials | 423 | 718 |
Packaging | 218 | 166 |
Inventories | $ 2,378 | $ 2,444 |
Note 6 - Property and Equipme_3
Note 6 - Property and Equipment (Details Textual) - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
Construction Payable, Current | $ 0.1 | $ 0.2 |
Construction in Progress, Gross | $ 1.2 | $ 0.9 |
Note 6- Property and Equipment
Note 6- Property and Equipment - Property, Plant and Equipment (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Property, plant, and equipment gross | $ 29,075 | $ 28,847 |
Property, plant, and equipment accumulated depreciation | 14,868 | 13,403 |
Property and equipment, net | 14,207 | 15,444 |
Land [Member] | ||
Property, plant, and equipment gross | 730 | 730 |
Furniture and Fixtures [Member] | ||
Property, plant, and equipment gross | $ 259 | 265 |
Furniture and Fixtures [Member] | Minimum [Member] | ||
Estimated useful lives (Year) | 5 years | |
Furniture and Fixtures [Member] | Maximum [Member] | ||
Estimated useful lives (Year) | 10 years | |
Plant [Member] | ||
Property, plant, and equipment gross | $ 10,095 | 10,457 |
Plant [Member] | Minimum [Member] | ||
Estimated useful lives (Year) | 20 years | |
Plant [Member] | Maximum [Member] | ||
Estimated useful lives (Year) | 40 years | |
Computer and Software [Member] | ||
Property, plant, and equipment gross | $ 450 | 452 |
Computer and Software [Member] | Minimum [Member] | ||
Estimated useful lives (Year) | 3 years | |
Computer and Software [Member] | Maximum [Member] | ||
Estimated useful lives (Year) | 5 years | |
Leasehold Improvements [Member] | ||
Property, plant, and equipment gross | $ 1,838 | 1,828 |
Leasehold Improvements [Member] | Minimum [Member] | ||
Estimated useful lives (Year) | 4 years | |
Leasehold Improvements [Member] | Maximum [Member] | ||
Estimated useful lives (Year) | 15 years | |
Machinery and Equipment [Member] | ||
Property, plant, and equipment gross | $ 15,703 | $ 15,115 |
Machinery and Equipment [Member] | Minimum [Member] | ||
Estimated useful lives (Year) | 5 years | |
Machinery and Equipment [Member] | Maximum [Member] | ||
Estimated useful lives (Year) | 15 years |
Note 7 - Intangible Assets an_3
Note 7 - Intangible Assets and Goodwill (Details Textual) - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 04, 2019 | Dec. 31, 2022 | Dec. 31, 2021 | |
Finite-Lived Intangible Assets, Remaining Amortization Period (Year) | 9 years 10 months 24 days | ||
Goodwill, Impairment Loss | $ 0 | $ 3,915 | |
Customer Relationships [Member] | |||
Finite-Lived Intangible Asset, Useful Life (Year) | 15 years | ||
Customer Relationships [Member] | MGI Grain Processing, LLC [Member] | |||
Finite-Lived Intangible Asset, Useful Life (Year) | 15 years |
Note 7 - Intangible Assets an_4
Note 7 - Intangible Assets and Goodwill - Intangible Assets, Excluding Goodwill (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Intangible assets, gross | $ 965 | $ 965 |
Intangible assets, accumulated amortization | 585 | 438 |
Intangible assets, net | $ 380 | 527 |
Customer Relationships [Member] | ||
Intangible assets, useful life (Year) | 15 years | |
Intangible assets, gross | $ 930 | 930 |
Intangible assets, accumulated amortization | 564 | 423 |
Intangible assets, net | $ 366 | 507 |
Trademarks [Member] | ||
Intangible assets, useful life (Year) | 10 years | |
Intangible assets, gross | $ 13 | 13 |
Intangible assets, accumulated amortization | 5 | 3 |
Intangible assets, net | $ 8 | 10 |
Noncompete Agreements [Member] | ||
Intangible assets, useful life (Year) | 5 years | |
Intangible assets, gross | $ 22 | 22 |
Intangible assets, accumulated amortization | 16 | 12 |
Intangible assets, net | $ 6 | $ 10 |
Note 7 - Intangible Assets an_5
Note 7 - Intangible Assets and Goodwill - Future Intangible Amortization (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
2023 | $ 111 | |
2024 | 80 | |
2025 | 58 | |
2026 | 42 | |
2027 | 31 | |
Thereafter | 58 | |
Total amortization | $ 380 | $ 527 |
Note 8 - Leases (Details Textua
Note 8 - Leases (Details Textual) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Finance Lease, Right-of-Use Asset, before Accumulated Amortization | $ 0.9 | |
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | 0.4 | $ 0.1 |
Property and Equipment [Member] | ||
Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total | $ 0.6 |
Note 8 - Leases - Components of
Note 8 - Leases - Components of Lease Expense and Cash Flows from Leases (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Amortization of right-of use assets, included in cost of goods sold | $ 97 | $ 89 |
Interest on lease liabilities | 21 | 11 |
Fixed leases cost | 515 | 515 |
Variable lease cost | 168 | 149 |
Short-term lease cost | 85 | 61 |
Total lease cost | 886 | 825 |
Operating cash flows from finance leases | 21 | 11 |
Operating cash flows from operating leases | 515 | 515 |
Financing cash flows from finance leases | $ 104 | $ 96 |
Note 8 - Leases - Remaining Ter
Note 8 - Leases - Remaining Terms and Discount Rates (Details) | Dec. 31, 2022 |
Weighted average remaining lease terms (in years), operating leases (Year) | 5 years 6 months |
Weighted average remaining lease terms (in years), finance leases (Year) | 4 years |
Weighted average discount rate, operating leases | 7.80% |
Weighted average discount rate, finance leases | 8.20% |
Minimum [Member] | |
Remaining leases terms (in years), operating leases (Year) | 9 months 18 days |
Remaining leases terms (in years), finance leases (Year) | 3 months 18 days |
Discount rates, operating leases | 6.30% |
Discount rates, finance leases | 2.80% |
Maximum [Member] | |
Remaining leases terms (in years), operating leases (Year) | 10 years 2 months 12 days |
Remaining leases terms (in years), finance leases (Year) | 4 years 9 months 18 days |
Discount rates, operating leases | 9% |
Discount rates, finance leases | 10.40% |
Note 8 - Leases - Maturities of
Note 8 - Leases - Maturities of Lease Liabilities (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
2023, operating leases | $ 528 |
2023, finance leases | 158 |
2024, operating leases | 429 |
2024, finance leases | 117 |
2025, operating leases | 439 |
2025, finance leases | 102 |
2026, operating leases | 451 |
2026, finance leases | 99 |
2027, operating leases | 232 |
2027, finance leases | 60 |
Thereafter, operating leases | 346 |
Thereafter, finance leases | 0 |
Total lease payments, operating leases | 2,425 |
Total lease payments, finance leases | 536 |
Amounts representing interest, operating leases | (477) |
Amounts representing interest, finance leases | (86) |
Present value of lease obligations, operating leases | 1,948 |
Present value of lease obligations, finance leases | $ 450 |
Note 9 - Debt (Details Textual)
Note 9 - Debt (Details Textual) - USD ($) | 1 Months Ended | 10 Months Ended | 12 Months Ended | ||||
Jan. 31, 2023 | Jan. 31, 2023 | Dec. 31, 2022 | Oct. 31, 2019 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 01, 2022 | |
Long-Term Debt, Gross | $ 2,301,000 | $ 2,301,000 | |||||
Factoring Agreement [Member] | Line of Credit [Member] | |||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 7,000,000 | ||||||
Debt Instrument, Term (Year) | 2 years | ||||||
Line of Credit Facility, Funding Fee, Percentage Above Prime Rate | 0.50% | ||||||
Line of Credit Facility, Funding Fee, Minimum Percentage | 5.50% | ||||||
Mortgage Agreement [Member] | |||||||
Debt Instrument, Interest Rate, Stated Percentage | 7% | 7% | 7% | ||||
Proceeds from Issuance of Debt | $ 900,000 | ||||||
Debt Instrument, Basis Spread on Variable Rate | 14.50% | 10.30% | |||||
Long-Term Debt, Gross | $ 1,300,000 | $ 1,300,000 | $ 2,500,000 | ||||
Proceeds from Issuance of Long-Term Debt, Total | $ 1,200,000 | ||||||
Mortgage Agreement [Member] | Subsequent Event [Member] | |||||||
Long-Term Debt, Gross | $ 1,300,000 | $ 1,300,000 | |||||
Mortgage Agreement [Member] | Prime Rate [Member] | |||||||
Debt Instrument, Interest Rate, Stated Percentage | 14.50% | 14.50% | |||||
Debt Instrument, Basis Spread on Variable Rate | 7% | ||||||
Mortgage Agreement [Member] | Prime Rate [Member] | Subsequent Event [Member] | |||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.30% | 10.30% | |||||
Old Note Prior to Modification [Member] | |||||||
Long-Term Debt, Gross | $ 1,300,000 | $ 1,300,000 | |||||
Mortgage Agreement, at Modification [Member] | |||||||
Long-Term Debt, Gross | $ 1.2 | $ 1.2 | |||||
Mortgage Agreement, at Modification [Member] | Subsequent Event [Member] | |||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.30% | 10.30% | |||||
Long-Term Debt, Gross | $ 2,500,000 | $ 2,500,000 | |||||
Proceeds from Issuance of Long-Term Debt, Total | 300,000 | ||||||
Mortgage Agreement, at Modification [Member] | Prime Rate [Member] | Subsequent Event [Member] | |||||||
Debt Instrument, Basis Spread on Variable Rate | 7% | ||||||
Original Mortgage Agreement [Member] | |||||||
Debt Instrument, Interest Rate, Stated Percentage | 14.30% | 14.30% | |||||
Debt Instrument, Periodic Payment, Total | $ 1 | ||||||
Original Mortgage Agreement [Member] | Prime Rate [Member] | |||||||
Debt Instrument, Basis Spread on Variable Rate | 11% | ||||||
Over Advance Note [Member] | Subsequent Event [Member] | |||||||
Long-Term Debt, Gross | $ 900,000 | $ 900,000 | |||||
Finance Agreements for Annual Insurance Premiums [Member] | Maximum [Member] | |||||||
Debt Instrument, Interest Rate, Stated Percentage | 3.90% | 3.90% |
Note 9 - Debt - Due Under Facto
Note 9 - Debt - Due Under Factoring Agreement (Details) - Line of Credit [Member] - Factoring Agreement [Member] - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Average borrowings outstanding (in thousands) | $ 3,179 | $ 1,622 |
Amortization of debt issuance costs (in thousands) | $ 0 | $ 75 |
Fees paid, as a percentage of average outstanding borrowings | 5.80% | 6.20% |
Interest paid, as a percentage of average outstanding borrowings | 7% | 6.40% |
Note 9 - Debt - Long-term Debt
Note 9 - Debt - Long-term Debt (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Total long term debt, net | $ 2,292 | $ 2,539 |
Total long term debt, net | 2,292 | 2,539 |
Other | 11 | |
Mortgage Agreement [Member] | ||
Total long term debt, net | 2,211 | 2,469 |
Total long term debt, net | 2,211 | 2,469 |
Progress Payment Agreement [Member] | ||
Total long term debt, net | 39 | 0 |
Total long term debt, net | 39 | 0 |
Equipment Notes, May 2021 [Member] | Notes Payable, Other Payables [Member] | ||
Total long term debt, net | 24 | 33 |
Total long term debt, net | 24 | 33 |
Equipment Notes, December 2019 [Member] | Notes Payable, Other Payables [Member] | ||
Total long term debt, net | 18 | 26 |
Total long term debt, net | $ 18 | $ 26 |
Note 9 - Debt - Long-term Deb_2
Note 9 - Debt - Long-term Debt (Details) (Parentheticals) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Mortgage Agreement [Member] | ||
Interest rate | 7% | 7% |
Interest rate, variable | 14.50% | 10.30% |
Original principal | $ 2.5 | $ 2.5 |
Maturity date | Jan. 31, 2025 | Jan. 31, 2025 |
Progress Payment Agreement [Member] | ||
Interest rate | 25.20% | |
Original principal | $ 37,000 | |
Equipment Notes, May 2021 [Member] | Notes Payable, Other Payables [Member] | ||
Original principal | $ 46,000 | $ 46,000 |
Maturity date | Jun. 30, 2025 | Jun. 30, 2025 |
Interest rate, effective rate | 3.60% | 3.60% |
Equipment Notes, December 2019 [Member] | Notes Payable, Other Payables [Member] | ||
Original principal | $ 40,000 | $ 40,000 |
Maturity date | Dec. 31, 2024 | Dec. 31, 2024 |
Interest rate, effective rate | 9.30% | 9.30% |
Note 9 - Debt - Future Principa
Note 9 - Debt - Future Principal Maturities of Long-term Debt Outstanding (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
2023 | $ 996 | |
2024 | 1,194 | |
2025 | 111 | |
Principal maturities | 2,301 | |
Debt issuance costs | (9) | |
Long-Term Debt, Total | $ 2,292 | $ 2,539 |
Note 10 - Equity, Share-based_3
Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings (Details Textual) - USD ($) | 1 Months Ended | 3 Months Ended | 10 Months Ended | 12 Months Ended | ||||||
Sep. 13, 2021 | Oct. 31, 2022 | Mar. 16, 2023 | Sep. 30, 2021 | Oct. 31, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2022 | Jul. 14, 2022 | Dec. 31, 2020 | |
Common Stock, Capital Shares Reserved for Future Issuance (in shares) | 1,088,457 | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance (in shares) | 2,298,769 | 875,067 | 664,592 | |||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance (in shares) | 55,424 | 64,396 | ||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total (in shares) | 8,972 | 3,107 | ||||||||
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price (in dollars per share) | $ 19.42 | |||||||||
Share-based Compensation Arrangement By Share-based Payment Award Options Forfeitures and Expirations, Weighted Average Remaining Contractual Term (Year) | 5 years 10 months 24 days | |||||||||
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | $ 70,000 | |||||||||
Share-Based Payment Arrangement, Option [Member] | ||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year) | 1 year 1 month 6 days | |||||||||
Restricted Stock Units (RSUs) [Member] | ||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested | $ 0.3 | |||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested | 0.2 | |||||||||
Restricted Stock Units (RSUs) [Member] | Subsequent Event [Member] | ||||||||||
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total (in shares) | 68,693 | |||||||||
Stock Units Issued (SUI) [Member] | ||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested | 0.1 | |||||||||
RSUs and SUs [Member] | ||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | 600,000 | |||||||||
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total | $ 1,200,000 | |||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year) | 2 years 9 months 18 days | |||||||||
Unvested RSU [Member] | ||||||||||
Common Stock, Capital Shares Reserved for Future Issuance (in shares) | 165,790 | |||||||||
Vested RSU [Member] | ||||||||||
Common Stock, Capital Shares Reserved for Future Issuance (in shares) | 224,725 | |||||||||
Stock Units [Member] | ||||||||||
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total | $ 0.2 | |||||||||
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares) | 160,000 | |||||||||
Stock Issued During Period, Shares, Restricted Stock Award, Cash Signing Fee | $ 0.2 | |||||||||
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year) | 2 years 8 months 12 days | |||||||||
Options, RSUs and SUs [Member] | ||||||||||
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total | $ 1,300,000 | |||||||||
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year) | 2 years 8 months 12 days | |||||||||
Warrant A [Member] | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 10 | $ 2.72 | ||||||||
Stock Issued During Period, Cashless Exercise Of Warrants Shares (in shares) | 230,750 | |||||||||
The 2014 Equity Incentive Plan [Member] | ||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) | 1,230,000 | 600,000 | ||||||||
Common Stock, Capital Shares Reserved for Future Issuance (in shares) | 141,543 | |||||||||
The 2014 Equity Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year) | 10 years | |||||||||
The 2014 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance (in shares) | 1,000,000 | |||||||||
The Prefunded Warrants [Member] | ||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 230,786 | 325,000 | 325,000 | |||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 0.001 | $ 0.0001 | $ 0.0001 | |||||||
Class of Warrant or Right, Exercise Price, Prefunded (in dollars per share) | $ 6.499 | $ 1.4999 | $ 1.4999 | |||||||
Warrants Issued in Private Placement [Member] | ||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 63,000 | 63,000 | ||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 1.875 | $ 1.875 | $ 1.60 | |||||||
Proceeds from Issuance or Sale of Equity, Total | $ 1,000,000 | |||||||||
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | $ 500,000 | |||||||||
Offering Cost Liability Outstanding | $ 300,000 | |||||||||
Warrants Issued in Private Placement [Member] | Maximum [Member] | ||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 2,000,000 | 2,000,000 | ||||||||
The Warrant [Member] | ||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 230,769 | |||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 10 | |||||||||
Class of Warrant or Right, Change in Exercise Price, Maximum Percentage of Five-day Volume Weighted Average Common Stock | 110% | |||||||||
Warrants and Rights Outstanding | $ 600,000 | |||||||||
Warrant A [Member] | ||||||||||
Class of Warrant or Right, Change in Exercise Price, Maximum Percentage of Five-day Volume Weighted Average Common Stock | 110% | |||||||||
Offering Pursuant to Shelf Registration Statement [Member] | ||||||||||
Stock Issued During Period, Shares, New Issues (in shares) | 230,750 | 675,000 | ||||||||
Proceeds from Issuance or Sale of Equity, Total | $ 2,800,000 | |||||||||
Payments of Stock Issuance Costs | $ 200,000 | |||||||||
At-the-market Offering Program [Member] | ||||||||||
Stock Issued During Period, Shares, New Issues (in shares) | 75,490 | |||||||||
Payments of Stock Issuance Costs | $ 100,000 | |||||||||
Shares Issued, Price Per Share (in dollars per share) | $ 8 | |||||||||
Proceeds from Issuance of Common Stock | $ 500,000 | |||||||||
Series A Through F Preferred Stock [Member] | ||||||||||
Preferred Stock, Shares Outstanding, Ending Balance (in shares) | 0 | |||||||||
Series G Preferred Stock [Member] | ||||||||||
Preferred Stock, Shares Outstanding, Ending Balance (in shares) | 150 | 150 | ||||||||
Convertible Preferred Stock, Shares Issued upon Conversion (in shares) | 94.89915 | |||||||||
Preferred Stock, Liquidation Preference Per Share (in dollars per share) | $ 1,000 |
Note 10 - Equity, Share-based_4
Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings - Share-based Compensation Expenses Related to Employees and Directors (Details) - The 2014 Equity Incentive Plan [Member] - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Compensation expense related to common stock awards issued under equity incentive plans | $ 1,261 | $ 1,114 |
Restricted Stock Units (RSUs) [Member] | ||
Compensation expense related to common stock awards issued under equity incentive plans | 1,160 | 866 |
Share-Based Payment Arrangement, Option [Member] | ||
Compensation expense related to common stock awards issued under equity incentive plans | 101 | 140 |
Common Stock, Vested at Issuance and Nonvested at Issuance [Member] | ||
Compensation expense related to common stock awards issued under equity incentive plans | $ 0 | $ 108 |
Note 10 - Equity, Share-based_5
Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings - Information Regarding Common Stock Issued (Details) - $ / shares | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Shares issued (in shares) | 137,698 | 70,858 |
Weighted Average Grant Date Fair Value Per Share (in dollars per share) | ||
Director [Member] | Common Stock [Member] | ||
Shares issued (in shares) | 34,875 | 13,608 |
Weighted Average Grant Date Fair Value Per Share (in dollars per share) | $ 6.71 | $ 7.95 |
Employees [Member] | Common Stock [Member] | ||
Shares issued (in shares) | 89,307 | 57,250 |
Weighted Average Grant Date Fair Value Per Share (in dollars per share) | $ 5.75 | $ 5.52 |
Consultants [Member] | Common Stock [Member] | ||
Shares issued (in shares) | 13,516 | 0 |
Weighted Average Grant Date Fair Value Per Share (in dollars per share) | $ 6.47 |
Note 10 - Equity, Share-based_6
Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings - Restricted Stock Unit Activity (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Nonvested, weighted average expense period (Year) | 2 years 10 months 24 days | 1 year 4 months 24 days | 1 year 1 month 6 days |
Restricted Stock Units (RSUs) [Member] | |||
Nonvested, shares issued (in shares) | 126,603 | 149,540 | |
Nonvested, unrecognized stock compensation | $ 658 | $ 730 | |
Nonvested, average grant date fair value (in dollars per share) | $ 5.20 | $ 4.88 | |
Nonvested, weighted average expense period (Year) | 2 years 9 months 18 days | 10 months 24 days | 1 year 4 months 24 days |
Granted, nonvested, shares issued (in shares) | 527,871 | 82,469 | |
Granted, unrecognized stock compensation | $ 1,680 | $ 796 | |
Granted, average grant date fair value (in dollars per share) | $ 3.18 | $ 9.65 | |
Granted, weighted average expense period (Year) | 2 years 8 months 12 days | 1 year | |
Granted, unrecognized stock compensation | $ 1,680 | $ 796 | |
Forfeited, shares issued (in shares) | (11,744) | (291) | |
Forfeited, unrecognized stock compensation | $ (68) | $ (3) | |
Forfeited, average grant date fair value (in dollars per share) | $ 5.77 | $ 10.31 | |
Forfeited, weighted average expense period (Year) | 1 year 1 month 6 days | 8 months 12 days | |
Vested with Service, shares issued (in shares) | (275,912) | (105,115) | |
Expensed, unrecognized stock compensation | $ (1,160) | $ (865) | |
Granted, weighted average expense period (Year) | 2 years 8 months 12 days | 1 year | |
Before modification, shares issued (in shares) | (17,050) | ||
Before modification, unrecognized stock compensation | $ (150) | ||
Before modification, average grant date fair value (in dollars per share) | $ 8.77 | ||
Before modification, weighted average expense period (Year) | 7 months 6 days | ||
After modification, shares issued (in shares) | 17,050 | ||
After modification | $ 64 | ||
After modification, average grant date fair value (in dollars per share) | $ 3.73 | ||
Nonvested, shares issued (in shares) | 366,818 | 126,603 | 149,540 |
Nonvested, unrecognized stock compensation | $ 1,024 | $ 658 | $ 730 |
Nonvested, average grant date fair value (in dollars per share) | $ 2.79 | $ 5.20 | $ 4.88 |
Vested, balance (in shares) | 86,505 | 38,640 | |
Vested with service (in shares) | 275,912 | 105,115 | |
Issued at vesting (in shares) | (83,725) | (57,250) | |
Issued at termination of service (in shares) | (53,967) | ||
Vested, balance (in shares) | 224,725 | 86,505 | 38,640 |
Stock Units Issued (SUI) [Member] | |||
Nonvested, shares issued (in shares) | 0 | 0 | |
Nonvested, unrecognized stock compensation | $ 0 | $ 0 | |
Nonvested, average grant date fair value (in dollars per share) | $ 0 | $ 0 | |
Nonvested, weighted average expense period (Year) | 2 years 8 months 12 days | ||
Granted, nonvested, shares issued (in shares) | 160,000 | 0 | |
Granted, unrecognized stock compensation | $ 216 | $ 0 | |
Granted, average grant date fair value (in dollars per share) | $ 1.35 | $ 0 | |
Granted, weighted average expense period (Year) | 3 years | ||
Granted, unrecognized stock compensation | $ 216 | $ 0 | |
Forfeited, shares issued (in shares) | 0 | 0 | |
Forfeited, unrecognized stock compensation | $ 0 | $ 0 | |
Forfeited, average grant date fair value (in dollars per share) | $ 0 | $ 0 | |
Vested with Service, shares issued (in shares) | 0 | 0 | |
Expensed, unrecognized stock compensation | $ (15) | $ 0 | |
Granted, weighted average expense period (Year) | 3 years | ||
Before modification, shares issued (in shares) | 0 | ||
Before modification, unrecognized stock compensation | $ 0 | ||
Before modification, average grant date fair value (in dollars per share) | $ 0 | ||
After modification, shares issued (in shares) | 0 | ||
After modification | $ 0 | ||
After modification, average grant date fair value (in dollars per share) | $ 0 | ||
Nonvested, shares issued (in shares) | 160,000 | 0 | 0 |
Nonvested, unrecognized stock compensation | $ 201 | $ 0 | $ 0 |
Nonvested, average grant date fair value (in dollars per share) | $ 1.26 | $ 0 | $ 0 |
Vested with service (in shares) | 0 | 0 |
Note 10 - Equity, Share-based_7
Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings - Warrants Activity (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Outstanding, balance (in shares) | 875,067 | 664,592 | |
Outstanding, weighted average exercise price (in dollars per share) | $ 9.76 | $ 9.82 | |
Nonvested, weighted average expense period (Year) | 2 years 10 months 24 days | 1 year 4 months 24 days | 1 year 1 month 6 days |
Issued (in shares) | 2,063,000 | 230,769 | |
Issued, weighted average exercise price (in dollars per share) | $ 1.61 | $ 10 | |
Issued, weighted average remaining contractual life (Year) | 3 years 1 month 6 days | 5 years | |
Before adjustment (in shares) | 230,769 | ||
Before adjustment, weighted average exercise price (in dollars per share) | $ 10 | ||
Before adjustment, weighted average remaining contractual life (Year) | 4 years | ||
After adjustment (in shares) | (230,769) | ||
After adjustment, weighted average exercise price (in dollars per share) | $ 2.72 | ||
After adjustment, weighted average remaining contractual life (Year) | 4 years | ||
Cash exercised (in shares) | (17,794) | ||
Cash exercised, weighted average exercise price (in dollars per share) | $ 9.60 | ||
Cash exercised, weighted average remaining contractual life (Year) | 9 months 18 days | ||
Expired (in shares) | (639,298) | (2,500) | |
Expired, weighted average exercise price (in dollars per share) | $ 9.60 | $ 52.50 | |
Outstanding, balance (in shares) | 2,298,769 | 875,067 | 664,592 |
Outstanding, weighted average exercise price (in dollars per share) | $ 1.76 | $ 9.76 | $ 9.82 |
Note 10 - Equity, Share-based_8
Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings - Exercisable and Outstanding (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Weighted Average Exercise Price (in dollars per share) | $ 1.76 | $ 9.76 | $ 9.82 |
Nonvested, weighted average expense period (Year) | 2 years 10 months 24 days | 1 year 4 months 24 days | 1 year 1 month 6 days |
Warrants [Member] | |||
Shares under warrants (in shares) | 2,298,769 | ||
Weighted Average Exercise Price (in dollars per share) | $ 1.76 | ||
Nonvested, weighted average expense period (Year) | 2 years 10 months 24 days | ||
Shares under warrants, exercisable (in shares) | 235,769 | ||
Weighted average exercise price, exercisable (in dollars per share) | $ 3.09 | ||
Weighted average remaining contractual term, exercisable (Year) | 3 years 7 months 6 days | ||
Warrants [Member] | Exercise Range One [Member] | |||
Shares under warrants (in shares) | 2,000,000 | ||
Weighted Average Exercise Price (in dollars per share) | $ 1.60 | ||
Nonvested, weighted average expense period (Year) | 2 years 9 months 18 days | ||
Shares under warrants, exercisable (in shares) | 0 | ||
Weighted average exercise price, exercisable (in dollars per share) | $ 0 | ||
Warrants [Member] | Exercise Price Range Two [Member] | |||
Shares under warrants (in shares) | 63,000 | ||
Weighted Average Exercise Price (in dollars per share) | $ 1.88 | ||
Nonvested, weighted average expense period (Year) | 4 years 9 months 18 days | ||
Shares under warrants, exercisable (in shares) | 0 | ||
Weighted average exercise price, exercisable (in dollars per share) | $ 0 | ||
Warrants [Member] | Exercise Price Range Three [Member] | |||
Shares under warrants (in shares) | 230,769 | ||
Weighted Average Exercise Price (in dollars per share) | $ 2.72 | ||
Nonvested, weighted average expense period (Year) | 3 years 8 months 12 days | ||
Shares under warrants, exercisable (in shares) | 230,769 | ||
Weighted average exercise price, exercisable (in dollars per share) | $ 2.72 | ||
Weighted average remaining contractual term, exercisable (Year) | 3 years 8 months 12 days | ||
Warrants [Member] | Exercise Price Range Four [Member] | |||
Shares under warrants (in shares) | 5,000 | ||
Weighted Average Exercise Price (in dollars per share) | $ 20 | ||
Nonvested, weighted average expense period (Year) | 1 month 6 days | ||
Shares under warrants, exercisable (in shares) | 5,000 | ||
Weighted average exercise price, exercisable (in dollars per share) | $ 20 | ||
Weighted average remaining contractual term, exercisable (Year) | 1 month 6 days |
Note 11 - Income Taxes (Details
Note 11 - Income Taxes (Details Textual) $ in Millions | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Domestic Tax Authority [Member] | |
Operating Loss Carryforwards | $ 54.4 |
Operating Loss Carryforwards, Subject To Expiration | $ 9.9 |
Domestic Tax Authority [Member] | Minimum [Member] | |
Operating Loss Carryforwards, Expiration Date | Dec. 31, 2023 |
Domestic Tax Authority [Member] | Maximum [Member] | |
Operating Loss Carryforwards, Expiration Date | Dec. 31, 2037 |
State and Local Jurisdiction [Member] | |
Operating Loss Carryforwards, Subject To Expiration | $ 46 |
State and Local Jurisdiction [Member] | Minimum [Member] | |
Operating Loss Carryforwards, Expiration Date | Jan. 01, 2023 |
State and Local Jurisdiction [Member] | Maximum [Member] | |
Operating Loss Carryforwards, Expiration Date | Dec. 31, 2042 |
Note 11 - Income Taxes - Deferr
Note 11 - Income Taxes - Deferred Tax Asset (Liability) (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Net operating loss carryforwards | $ 14,264 | $ 13,385 | |
Stock options and warrants | 1,151 | 832 | |
Property and equipment | (46) | (16) | |
Intangible assets | 875 | 950 | |
Capitalized expenses | 117 | 105 | |
Other | 655 | 64 | |
Operating right-of-use lease assets | (478) | (566) | |
Operating right-of-use lease liabilities | 645 | 670 | |
Net deferred tax assets | 17,183 | 15,456 | |
Less: Valuation allowance | (17,183) | (15,456) | $ (12,421) |
Deferred tax asset (liability) | $ 0 | $ 0 |
Note 11 - Income Taxes - Summar
Note 11 - Income Taxes - Summarizes the Changes in the Valuation Allowance (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Valuation allowances, beginning of year | $ 15,456 | $ 12,421 |
Net operating loss and other temporary differences | 1,997 | 2,926 |
Expiration of net operating losses and limitations | (90) | 0 |
Adjustment to deferred taxes | (197) | 67 |
Impact of state tax rate change | 22 | 42 |
Other | (5) | 0 |
Valuation allowance, end of year | $ 17,183 | $ 15,456 |
Note 11 - Income Taxes - Income
Note 11 - Income Taxes - Income Tax Expense (Benefit) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Income tax benefit at federal statutory rate | $ (1,646) | $ (1,875) |
State tax benefit, net of federal tax effect | (421) | (605) |
Effect of change in state tax rate | (22) | (42) |
Change in valuation allowance | 1,727 | 3,035 |
Expirations of net operating losses and application of IRC 382 limitation | 90 | 0 |
PPP loan forgiveness, nontaxable | 0 | (376) |
Change in fair value of derivative warrant liability, nontaxable | 5 | (81) |
Other nondeductible expenses | 89 | 32 |
Adjustments to deferreds | 197 | (67) |
Income tax expense | $ 19 | $ 21 |
Note 12 - Income (Loss) Per S_3
Note 12 - Income (Loss) Per Share (EPS) - EPS Computations (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Basic and diluted - net loss | $ (7,858) | $ (8,949) |
Weighted average number of shares of shares of common stock outstanding (in shares) | 5,414,079 | 4,710,567 |
Weighted average number of shares of common stock underlying vested restricted stock units (in shares) | 100,592 | 63,328 |
Basic EPS - weighted average number of shares outstanding (in shares) | 5,514,671 | 4,773,895 |
Diluted EPS - weighted average number of shares outstanding (in shares) | 5,514,671 | 4,773,895 |
Note 13 - Fair Value Measurem_3
Note 13 - Fair Value Measurements (Details Textual) - Fair Value, Recurring [Member] - Fair Value, Inputs, Level 3 [Member] $ / shares in Units, $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) $ / shares | |
Operating Lease, Fair Value In Excess Of Carrying Amount | $ 200 |
Measurement Input, Exercise Price [Member] | |
Warrant, Exercise Price, Increase (in dollars per share) | $ / shares | $ 0.10 |
Fair Value Adjustment of Warrants | $ 10 |
Note 13 - Fair Value Measurem_4
Note 13 - Fair Value Measurement - Fair Value of Liabilities on Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Derivative warrant liability | $ 69 | $ 258 |
Total liabilities at fair value | 69 | 258 |
Fair Value, Inputs, Level 1 [Member] | ||
Derivative warrant liability | 0 | 0 |
Total liabilities at fair value | 0 | 0 |
Fair Value, Inputs, Level 2 [Member] | ||
Derivative warrant liability | 0 | 0 |
Total liabilities at fair value | 0 | 0 |
Fair Value, Inputs, Level 3 [Member] | ||
Derivative warrant liability | 69 | 258 |
Total liabilities at fair value | $ 69 | $ 258 |
Note 13 - Fair Value Measurem_5
Note 13 - Fair Value Measurement - Changes in Level 3 Items Measured at Fair Value (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Fair value as of beginning of period | $ 258 | $ 0 |
Total realized and unrealized gains (losses) | (189) | 0 |
Issuance of new instruments | 0 | 647 |
Net transfers (into) out of level 3 | 0 | 0 |
Fair value at end of period | 69 | 258 |
Change in unrealized gains (losses) on instruments still held | (189) | (389) |
Total realized and unrealized gains (losses) | $ 189 | $ 0 |
Note 12 - Fair Value Measuremen
Note 12 - Fair Value Measurement - Fair Value Assumption Measurement of Warrant A (Details) | Dec. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 |
Warrants and Rights Outstanding, Measurement Input | 2.72 | 10 | 10 |
Measurement Input, Price Volatility [Member] | |||
Warrants and Rights Outstanding, Measurement Input | 92.2 | 69.5 | 71 |
Measurement Input, Risk Free Interest Rate [Member] | |||
Warrants and Rights Outstanding, Measurement Input | 0.043 | 0.008 | 0.004 |
Measurement Input, Expected Term [Member] | |||
Warrants and Rights Outstanding, Measurement Input | 4 | 4.8 | 5 |
Measurement Input, Expected Dividend Rate [Member] | |||
Warrants and Rights Outstanding, Measurement Input | 0 | 0 | 0 |
Note 14 - Commitments and Con_2
Note 14 - Commitments and Contingencies (Details Textual) - USD ($) $ in Thousands | Jan. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Apr. 30, 2020 |
Long-Term Debt, Total | $ 2,292 | $ 2,539 | ||
Subsequent Event [Member] | ||||
Proceeds from Legal Settlements | $ 300 | |||
Paycheck Protection Program CARES Act [Member] | ||||
Long-Term Debt, Total | $ 1,800 |